Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH-funded cancer study

This article was originally published in The Tan Sheet

Executive Summary

The National Institutes of Health awards Omaha, Neb.-based Creighton University $4 million to continue a "landmark" study linking vitamin D to reduced cancer risk. The original study, headed by Joan Lappe and reported in June 2007, showed for the first time in a clinical setting that postmenopausal women consuming calcium and vitamin D3 supplements at nearly three times the recommended levels could reduce the risk of cancer by 60-77 percent, the university says Jan. 26. "We must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer," Lappe says. "Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D." The four-year study begins in April and will follow 2,300 healthy, postmenopausal women from Nebraska
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS102557

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel